MeSH term
Frequency | Condition_Probility | Amyloid/*genetics | 9 | 25.0 |
Animals | 20 | 0.0 |
Creutzfeldt-Jakob Syndrome/genetics | 3 | 30.0 |
Disease Models, Animal | 4 | 0.0 |
Humans | 57 | 0.0 |
Mice | 13 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Mutation | 11 | 0.0 |
PrPC Proteins/genetics | 2 | 50.0 |
PrPSc Proteins/genetics | 2 | 66.0 |
Protein Precursors/*genetics | 10 | 7.0 |
Brain/pathology | 7 | 2.0 |
Comparative Study | 14 | 0.0 |
Polymorphism, Genetic | 8 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
Base Sequence | 11 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Creutzfeldt-Jakob Syndrome/*genetics | 9 | 47.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Prions/*genetics | 20 | 37.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Transfection | 2 | 0.0 |
Adult | 23 | 0.0 |
Female | 23 | 0.0 |
Gene Frequency | 6 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Male | 23 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Blotting, Western | 4 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Middle Aged | 20 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Models, Molecular | 3 | 0.0 |
Prions/*genetics/metabolism | 2 | 28.0 |
Age of Onset | 7 | 0.0 |
Aged | 16 | 0.0 |
PrPC Proteins/*genetics | 3 | 60.0 |
Models, Biological | 2 | 0.0 |
Age Factors | 6 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Genotype | 12 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Incidence | 2 | 0.0 |
Pedigree | 8 | 0.0 |
Prions/genetics/metabolism | 2 | 50.0 |
Adolescent | 3 | 0.0 |
Alleles | 10 | 0.0 |
*Amino Acid Substitution | 2 | 2.0 |
Apoptosis | 2 | 0.0 |
Child | 3 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
Disease Progression | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
Prions/biosynthesis/*genetics | 2 | 100.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
English Abstract | 4 | 0.0 |
14-3-3 Proteins | 2 | 1.0 |
Electroencephalography | 4 | 1.0 |
Phenotype | 8 | 0.0 |
Valine/genetics | 4 | 5.0 |
Mice, Transgenic | 2 | 0.0 |
Codon/*genetics | 4 | 6.0 |
Haplotypes | 2 | 0.0 |
Amyloid/genetics | 5 | 38.0 |
Diagnosis, Differential | 2 | 0.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Point Mutation/genetics | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Protein Precursors/genetics | 4 | 4.0 |
Heterozygote | 3 | 0.0 |
Chromosomes, Human, Pair 20 | 2 | 4.0 |
Codon | 7 | 1.0 |
Point Mutation | 4 | 0.0 |
Retrospective Studies | 2 | 0.0 |
Valine | 2 | 3.0 |
*Variation (Genetics) | 2 | 0.0 |
Apolipoproteins E/genetics | 2 | 0.0 |
Homozygote | 3 | 0.0 |
Methionine/chemistry | 2 | 14.0 |
Polymerase Chain Reaction | 8 | 0.0 |
*Polymorphism, Genetic | 5 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
Valine/chemistry | 2 | 9.0 |
Prions/*chemistry/*genetics | 2 | 66.0 |
Mice, Inbred C57BL | 2 | 0.0 |
*Point Mutation | 3 | 0.0 |
Codon/genetics | 4 | 1.0 |
Hamsters | 3 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Cattle | 2 | 0.0 |
Guinea Pigs | 3 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
PrPSc Proteins | 2 | 7.0 |
*Chromosomes, Human, Pair 20 | 2 | 1.0 |
Brain Chemistry | 2 | 0.0 |
Creutzfeldt-Jakob Syndrome/*genetics/pathology/transmission | 2 | 100.0 |
Genes, Structural | 2 | 0.0 |
PrPC Proteins | 2 | 50.0 |
Amino Acid Substitution | 2 | 0.0 |
Variation (Genetics)/*genetics | 2 | 0.0 |
Methionine/genetics | 3 | 6.0 |
